a year ago
SRPT
AnalystsGil BlumGil Blum's Stock Forecasts
AnalystsGil Blum
Sectors:
Industries:
Analyst Ranking
Top 5%
#232 out of 5061 analysts
Average Return
+8.46%
Win Rate
41%177 out of 430
Risk vs Reward
Poor
Good
Gil Blum's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
I MabIMAB | +791.18% | $0.68 | $6.06 | 2025-04-04 - 2025-10-14 | Buy |
Celcuity IncCELC | +400.54% | $9.23 | $46.20 | 2025-04-11 - 2025-10-14 | Buy |
Celcuity IncCELC | +397.31% | $9.29 | $46.20 | 2025-04-01 - 2025-10-14 | Buy |
Mereo Biopharma Group PLCMREO | +364.14% | $0.71 | $3.30 | 2023-03-30 - 2024-03-28 | Buy |
Taysha Gene Therapies IncTSHA | +341.54% | $0.65 | $2.87 | 2023-03-29 - 2024-03-28 | Buy |
Gil Blum Analyst Color
Get additional color on Gil Blum's coverage of popular stocks
2 years ago
AUTL
2 years ago
AUTL
Gil Blum's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crispr Therapeutics AgCRSP | 25 | Buy | $81.00 | +16.75% | Reiterates | 5 days ago |
Celcuity IncCELC | 20 | Buy | $70.00 | +51.52% | Reiterates | 12 days ago |
Taysha Gene Therapies IncTSHA | 30 | Buy | $10.00 | +93.99% | Maintains | 13 days ago |
Amicus Therapeutics IncFOLD | 2 | Buy | $14.00 | +74.13% | Upgrades | a month ago |
Recursion Pharmaceuticals IncRXRX | 25 | Buy | $8.00 | +35.82% | Reiterates | a month ago |
I MabIMAB | 17 | Buy | $6.00 | -0.99% | Reiterates | a month ago |
Generation Bio CoGBIO | 18 | Buy | $15.00 | +131.48% | Reiterates | 2 months ago |
Nkarta IncNKTX | 17 | Buy | $10.00 | +318.41% | Reiterates | 2 months ago |
Absci CorpABSI | 5 | Buy | $8.00 | +105.13% | Maintains | 2 months ago |
Autolus Therapeutics PLCAUTL | 29 | Buy | $10.00 | +517.28% | Reiterates | 3 months ago |
Sarepta Therapeutics IncSRPT | 33 | Hold | $50.00 | +133.32% | Downgrades | 3 months ago |
Mereo Biopharma Group PLCMREO | 19 | Buy | $5.00 | +155.10% | Maintains | 3 months ago |
Rocket Pharmaceuticals IncRCKT | 21 | Hold | $42.00 | +883.61% | Downgrades | 5 months ago |
Artiva Biotherapeutics IncARTV | 6 | Buy | $18.00 | +527.18% | Maintains | 5 months ago |
Cartesian Therapeutics IncRNAC | 23 | Buy | $40.00 | +324.63% | Maintains | 5 months ago |
Nurix Therapeutics IncNRIX | 24 | Buy | $27.00 | +194.12% | Reiterates | 6 months ago |
Immunocore Holdings PLCIMCR | 14 | Buy | $71.00 | +123.83% | Reiterates | 6 months ago |
Tscan Therapeutics IncTCRX | 7 | Buy | $9.00 | +326.54% | Reiterates | 6 months ago |
Geron CorpGERN | 22 | Buy | $5.00 | +303.23% | Reiterates | 7 months ago |
Arcellx IncACLX | 22 | Buy | $105.00 | +20.23% | Reiterates | 10 months ago |
Shattuck Labs IncSTTK | 13 | Hold | $8.00 | N/A | Downgrades | a year ago |
Nextcure IncNXTC | 9 | Buy | $48.00 | N/A | Reiterates | a year ago |
G1 Therapeutics IncGTHX | 17 | Buy | $6.00 | N/A | Maintains | a year ago |
Gamida Cell LtdGMDAQ | 8 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Cti Biopharma CorpCTIC | 5 | Buy | $9.00 | N/A | Reiterates | 2 years ago |
Tectonic Therapeutic IncTECX | 4 | Buy | $72.00 | N/A | Reiterates | 3 years ago |
Fate Therapeutics IncFATE | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.